Supply of Quadrivalent/Trivalent Seasonal Influenza Vaccine (SIV) for Haj Session 2026

Select, Excess (+), Less (-)

Tender Inviting Authority: Govt. Medical Store Depot New Delhi ,Medical Store Organization, DGHS

Name of Work: Supply of Quadrivalent/Trivalent Seasonal Influenza Vaccine (SIV) for Haj Session 2026

Contract No: PS/2/SIV/Haj Session 2026/2025-26/05

Name of the Bidder/ Bidding Firm / Company :

Sl. No. Item Description ( Nomenclature + Strength + Dosage Form + Specification) VMS No Quantity Required in doses Pack Size Estimated Rate in Rs. P Addition / Deduction Addition / Deduction Values Currency Convertion against each Item Quoted Currency in INR / Other Currency Basic Price Quoted per Rate Unit(R/U) in Rs per Rate Unit(R/U) in Rs GST ( in Percentage) GST Amount in Rs. P HSN / SAC Code TOTAL AMOUNT excluding taxes in Rs. P Price offered(Inclusive of GSTper Rate Unit (R/U)in Rs Price Offered per Rate Unit(R/U) In Words

1 Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As per the WHO recommendations the Quadrivalent vaccines for use in the 2026 influenza season (NH) contain the following: Egg-based Vaccines • an A/Victoria/4897/2022 (H1N1)pdm09-like virus; • an A/Thailand/8/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • aB/Phuket/3073/2013 (B/Yamagata lineage)-like virus Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV8 1 Prefilled Syringe (PFS) 0 Excess(+) Full Conversion INR 1.01 Supplying, Conveying and fixing spls. Including eart item1 123.223 Nos

2 Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As per the WHO recommendations the Quadrivalent vaccines for use in the 2026 influenza season (NH) contain the following: Egg-based Vaccines • an A/Victoria/4897/2022 (H1N1)pdm09-like virus; • an A/Thailand/8/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • aB/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV9 1 Multi-dose Vial 0 Excess(+) Full Conversion INR 1.02 Construction of chamber for 100mm sluice plates item2 213 Nos

3 Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As per the WHO recommendations the Quadrivalent vaccines for use in the 2026 influenza season (NH) contain the following: Egg-based Vaccines • an A/Victoria/4897/2022 (H1N1)pdm09-like virus; • an A/Thailand/8/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • aB/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV12 1 Single Dose Vial 0 Excess(+) Full Conversion INR 2 Construction of chamber for 100mm sluices valve item3 10 Nos

4 Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2026 influenza season (NH) contain the following: Egg-based Vaccines • an A/Victoria/4897/2022 (H1N1)pdm09-like virus; • an A/Thailand/8/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV10 1 Prefilled Syringe (PFS) 0 Excess(+) Full Conversion INR 1.01 Supplying, Conveying and fixing spls. Including eart item1 123.223 Nos

5 Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2026 influenza season (NH) contain the following: Egg-based Vaccines • an A/Victoria/4897/2022 (H1N1)pdm09-like virus; • an A/Thailand/8/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV11 1 Multi-dose Vial 0 Excess(+) Full Conversion INR 1.02 Construction of chamber for 100mm sluice plates item2 213 Nos

6 Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2026 influenza season (NH) contain the following: Egg-based Vaccines • an A/Victoria/4897/2022 (H1N1)pdm09-like virus; • an A/Thailand/8/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV13 1 Single Dose Vial 0 Excess(+) Full Conversion INR 2 Construction of chamber for 100mm sluices valve item3 10 Nos

7 Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As per the WHO recommendations the Quadrivalent vaccines for use in the 2026 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; • an A/Massachusetts/18/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV14 1 Prefilled Syringe (PFS) 0 Excess(+) Full Conversion INR 1.01 Supplying, Conveying and fixing spls. Including eart item1 123.223 Nos

8 Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As per the WHO recommendations the Quadrivalent vaccines for use in the 2026 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; • an A/Massachusetts/18/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV15 1 Multi-dose Vial 0 Excess(+) Full Conversion INR 1.02 Construction of chamber for 100mm sluice plates item2 213 Nos

9 Seasonal Influenza Vaccine(Quadrivalent) (For Adults) Specification: As per the WHO recommendations the Quadrivalent vaccines for use in the 2026 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; • an A/Massachusetts/18/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV16 1 Single Dose Vial 0 Excess(+) Full Conversion INR 2 Construction of chamber for 100mm sluices valve item3 10 Nos

10 Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2026 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; • an A/Massachusetts/18/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV17 1 Prefilled Syringe (PFS) 0 Excess(+) Full Conversion INR 1.01 Supplying, Conveying and fixing spls. Including eart item1 123.223 Nos

11 Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2026 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; • an A/Massachusetts/18/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV18 1 Multi-dose Vial 0 Excess(+) Full Conversion INR 1.02 Construction of chamber for 100mm sluice plates item2 213 Nos

12 Seasonal Influenza Vaccine(Trivalent) (For Adults) Specification: As per the WHO recommendations the Trivalent vaccines for use in the 2026 influenza season (NH) contain the following: Cell- or recombinant-based Vaccines • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; • an A/Massachusetts/18/2022 (H3N2)-like virus; • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery. Minimum Shelf Life: 12 Months NIV19 1 Single Dose Vial 0 Excess(+) Full Conversion INR 2 Construction of chamber for 100mm sluices valve item3 10 Nos

Total in Figures 4 Construction of chamber for 100mm sluice plates item5 10 Nos

Quoted Rate in Figures Select %

Quoted Rate in Words